Instrument Inactif

Communiqués Lpath, Inc. Nasdaq

Actions

US5489103060

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

2023	Boston Scientific Corporation (NYSE:BSX) a finalisé l'acquisition d'Apollo Endosurgery, Inc. (NasdaqGM:APEN) auprès d'un groupe d'actionnaires.	CI
2023	APOLLO ENDOSURGERY, INC. : Cowen moins optimiste	ZM

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

APOLLO ENDOSURGERY, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, (form 8-K)	04/04/23	AQ
APOLLO ENDOSURGERY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	30/03/23	AQ
Apollo Endosurgery : Submission of Matters to a Vote of Security Holders - Form 8-K	10/02/23	PU
APOLLO ENDOSURGERY, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	10/02/23	AQ
APOLLO ENDOSURGERY, INC. : Unregistered Sale of Equity Securities (form 8-K)	29/12/22	AQ
Apollo Endosurgery : Merger Agreement - Form 8-K	28/12/22	PU
APOLLO ENDOSURGERY, INC. : Other Events (form 8-K)	28/12/22	AQ
Apollo Endosurgery To Be Acquired By Boston Scientific	05/12/22	AQ
APOLLO ENDOSURGERY, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	30/11/22	AQ
APOLLO ENDOSURGERY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apollo Endosurgery, Inc. - APEN	30/11/22	BU
APOLLO ENDOSURGERY, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	29/11/22	AQ
APOLLO ENDOSURGERY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	01/11/22	AQ
Apollo Endosurgery : THIRD AMENDMENT TO OFFICE LEASE AGREEMENT - Form 8-K	06/10/22	PU
APOLLO ENDOSURGERY, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	06/10/22	AQ
Apollo Endosurgery : Reports Record Global Revenue in Second Quarter 2022 - Form 8-K	02/08/22	PU
APOLLO ENDOSURGERY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	02/08/22	AQ
Apollo Endosurgery : FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG™ and Apollo REVISE™, New Endoscopic Systems for Patients with Obesity - Form 8-K	13/07/22	PU
APOLLO ENDOSURGERY, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	13/07/22	AQ
Apollo Endosurgery : Sharon O’Keefe Joins Apollo Endosurgery Board of Directors - Form 8-K	06/07/22	PU
APOLLO ENDOSURGERY, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	06/07/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Lpath, Inc. Nasdaq

Actions

US5489103060

Communiqués

Filtres